Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Kardiologiia ; 61(4): 39-45, 2021 May 04.
Article in English, English | MEDLINE | ID: mdl-33998407

ABSTRACT

Aim      To study the effects of pre- and postoperative anemia on the risk and the structure of internal organ dysfunction in patients undergoing surgery for acquired heart diseases (AHD).Material and methods  This was a retrospective cohort study including 610 primarily operated patients with AHD. A comparative analysis of the incidence and the structure of internal organ dysfunction was performed, and the likelihood of intraoperative hemotransfusion was determined for patients with preoperative anemia (Hb <130 g/l) and without it. The incidence and the nature of internal organ damage were compared in patients with postoperative Hb < 90 g/l and 90-130 g/l.Results The presence of postoperative anemia detected in 45 % of patients at two days after the surgery 6-fold increased the risk of acute heart failure (odds ratio [OR], 5.75; 95 % confidence interval [CI], 1.23-26.84; р=0.016), 4-fold increased the risk of multiorgan failure (MOF) (OR, 4.2; 95 % CI, 1.16-15.64; р=0.03), and 5-fold increased the likelihood of hemotransfusion (OR, 4.74; 95 % CI, 3.12-7.19; р<0.0001). Severe and moderate anemia (Hb <90 g/l) was observed in 11.2 % of patients, which presence 6-fold increased the risk of brain dysfunction (OR, 5.72; 95 % CI, 2.17-15.06; р=0.001) and MOF (OR, 5.97; 95 % CI, 1.94-18.35; р=0.004) compared to patients with Hb 90-130 g/l.Conclusion      In patients with AHD, postoperative anemia increases the risk of circulatory decompensation at two days after the surgery and of MOF and also increases the likelihood of intraoperative hemotransfusion; postoperative anemia with Hb <90 g/l increases the risk of brain damage and MOF.


Subject(s)
Anemia , Multiple Organ Failure , Anemia/epidemiology , Anemia/etiology , Heart Valves , Humans , Multiple Organ Failure/epidemiology , Multiple Organ Failure/etiology , Retrospective Studies , Risk Factors
2.
Kardiologiia ; 60(11): 1303, 2020 Dec 15.
Article in Russian | MEDLINE | ID: mdl-33487146

ABSTRACT

Aim To analyze survival of patients with COVID-19 based on echocardiographic (EchoCG) criteria for evaluation of the right ventricular (RV) systolic function.Material and methods Data of patients were retrospectively evaluated at the Center for Medical Care of Patients with Coronavirus Infection. Among 142 primarily evaluated patients with documented COVID-19, 110 patients (men/women, 63/47; mean age, 62.3 ± 15.3 years) met inclusion/exclusion criteria. More than 30 EchoCG parameters were analyzed, and baseline data (comorbidities, oxygen saturation, laboratory data, complications, outcomes, etc.) were evaluated. ROC-analysis was used for evaluating the diagnostic significance of different EchoCG parameters for prediction of a specific outcome and its probability. Dependence of the overall survival of patients on different EchoCG parameters was analyzed with the Cox proportional hazards model. For assessing the predictive value of EchoCG parameters for patient stratification by risk of an adverse outcome, a predictive model was developed using the CHAID method.Results The in-hospital death rate of patients included into the study was 15.5 %, and the death rate for this period of in-hospital observation was 12 %. Based on the single-factor analysis of EchoCG parameters, a multifactor model was developed using the method of Cox regression. The model included two predictors for an unfavorable outcome, estimated pulmonary artery systolic pressure (EPASP) and maximal indexed right atrial volume (RAi), and a preventive factor, right ventricular global longitudinal strain (LS RV). Base risks for fatal outcome were determined with an account of the follow-up time. According to the obtained values, an increase in EPASP by 1 mm Hg was associated with increases in the risk of fatal outcome by 8.6 % and in the RA(i) volume by 1 ml/5.8 %. LS RV demonstrated an inverse correlation; a 1% increase in LS RV was associated with a 13.4% decrease in the risk for an unfavorable outcome. According to the ROC analysis, the most significant determinants of the outcome were the tricuspid annular plane systolic excursion (TAPSE) (AUC, 0.84 ± 0.06; cut-off, 18 mm) and EPASP (AUC, 0.86 ± 0.05; cut-off, 42 mm Hg). Evaluating the effects of different EchoCG predictors, that characterized the condition of the right heart, provided a classification tree. Six final decisions were determined in the model, two of which were assigned to the category of reduced risk for fatal outcome and four were assigned to the category of increased risk. Sensitivity of the classification tree model was 94.1 % and specificity was 89.2 %. Overall diagnostic significance was 90.0±2.9 %.Conclusion The presented models for statistical treatment of EchoCG parameters reflect the requirement for a comprehensive analysis of EchoCG parameters based on a combination of standard methods for EchoCG evaluation and current technologies of noninvasive visualization. According to the study results, the new EchoCG marker, LS RV, allows identifying the signs of right ventricular dysfunction (particularly in combination with pulmonary hemodynamic indexes), may enhance the early risk stratification in patients with COVID-19, and help making clinical decisions for patients with different acute cardiorespiratory diseases.


Subject(s)
COVID-19 , Ventricular Dysfunction, Right , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies , SARS-CoV-2 , Ventricular Dysfunction, Right/diagnosis , Ventricular Function, Right
3.
Anesteziol Reanimatol ; 60(5): 42-6, 2015.
Article in Russian | MEDLINE | ID: mdl-26852579

ABSTRACT

The article deals with the safety and efficiency of recombinant activated factor VII (Coagil VII, Russia) and prothrombin complex concentrate (protromplex-600, Baxter Austria) in the neonatal and pediatric cardiac surgery. The study included 56 children aged from 7 days to 5.5 years underwent surgery with cardiopulmonary bypass for congenital heart defects repair. Clinical and laboratory evidences suggest that Coagil VII and protromplex-600 effective for bleeding stop. The drugs have no negative impact on hemodynamics. We did not identify allergic reactions and thrombosis associated with the introduction of drugs in the pen operative period.


Subject(s)
Cardiac Surgical Procedures/methods , Coagulants/therapeutic use , Factor IX/therapeutic use , Factor VII/therapeutic use , Factor VIIa/therapeutic use , Factor X/therapeutic use , Heart Defects, Congenital/surgery , Hemostasis, Surgical/methods , Prothrombin/therapeutic use , Child, Preschool , Coagulants/administration & dosage , Drug Combinations , Extracorporeal Circulation , Factor IX/administration & dosage , Factor VII/administration & dosage , Factor VIIa/administration & dosage , Factor X/administration & dosage , Heart Defects, Congenital/blood , Humans , Infant , Infant, Newborn , Prothrombin/administration & dosage , Treatment Outcome
4.
Anesteziol Reanimatol ; 60(5): 80-4, 2015.
Article in Russian | MEDLINE | ID: mdl-26852586

ABSTRACT

The article deals with a survey of the main pharmacological effects of levosimendane. Special attention is paid to cardiac and organ protective properties of the medication. The article reviews literature data on the efficacy of levosimendan in various fields of medicine and in the experiment and highlights the problem of heart failure and low cardiac output syndrome treatment in cardiology and cardiac surgery.


Subject(s)
Cardiac Output, Low/drug therapy , Cardiotonic Agents/therapeutic use , Heart Failure/drug therapy , Hydrazones/therapeutic use , Pyridazines/therapeutic use , Animals , Cardiotonic Agents/administration & dosage , Cardiotonic Agents/adverse effects , Clinical Trials as Topic , Humans , Hydrazones/administration & dosage , Hydrazones/adverse effects , Pyridazines/administration & dosage , Pyridazines/adverse effects , Simendan , Treatment Outcome
5.
Lab Chip ; 14(12): 2096-104, 2014 Jun 21.
Article in English | MEDLINE | ID: mdl-24800721

ABSTRACT

The development of novel cellular models that can replace animals in preclinical trials of drug candidates is one of the major goals of cell engineering. Current in vitro screening methods hardly correspond with the in vivo situation, whereas there is a lack of assays for more accurate cell culture models. Therefore, development of automated assays for 3D cell culture models is urgently required. In this work, we present a SpheroChip system: a microfluidic-based platform for long-term 3D cell culture and analysis. The system is compatible with commercially available microplate readers and provides continuous, in situ monitoring of tumour spheroids cultured on a chip. The microfluidic chip consists of cell culture microchambers and hemispherical microwells connected with a concentration gradient generator. HT-29 and Hep-G2 cells were successfully cultured as tumour spheroids in the SpheroChip, and metabolic activity of cells was monitored for up to two weeks by in situ fluorimetric measurements. Cellular response to an anticancer drug was observed using the SpheroChip. The experimental setup provided the unique possibility of observing dynamic changes in metabolic activity of one culture during sequencing days after drug dosage. According to this new approach, unknown phenomena of cellular response to the anticancer drug were observed, such as increase of metabolic activity shortly after drug dosage. Moreover, the influence of a second dose of a drug was evaluated. The SpheroChip system can be used by researchers working on drug screening, evaluation of anticancer procedures and chemoresistance phenomena.


Subject(s)
Drug Screening Assays, Antitumor , Microfluidic Analytical Techniques , Neoplasms , Spheroids, Cellular , Cell Culture Techniques , Cell Line, Tumor , Drug Screening Assays, Antitumor/instrumentation , Drug Screening Assays, Antitumor/methods , Humans , Microfluidic Analytical Techniques/instrumentation , Microfluidic Analytical Techniques/methods , Neoplasms/metabolism , Neoplasms/pathology , Spheroids, Cellular/metabolism , Spheroids, Cellular/pathology
6.
Farmaco ; 58(12): 1235-42, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14630233

ABSTRACT

The different dialkyl and diaryl diselenides with carbamoyl and sulfamoyl moieties 2, 3, 5 and other substituents in the ortho position of benzene ring 4, 7, 8 as well as derivatives of 1,2,4-benzoselenadiazine (6) were designed as antiviral and antimicrobial agents and synthesized. Some of them, particularly 8a and 8b, were found in the antiviral assay in vitro to be strong inhibitors of cytopathic activity encephalomyocarditis virus (EMCV). The compound 4a and 8a were found to have a broad spectrum of acivity against bacteria, yeasts and pathogenic fungi in vitro.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Antiviral Agents/chemical synthesis , Organoselenium Compounds/chemical synthesis , Animals , Anti-Bacterial Agents/pharmacology , Antiviral Agents/pharmacology , Cell Line, Tumor , Humans , Mice , Microbial Sensitivity Tests/methods , Organoselenium Compounds/pharmacology
10.
Am Ind Hyg Assoc J ; 57(8): 712-6, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8765199

ABSTRACT

This study determined the origin of pituitary lesions found in male ND4 Swiss Webster mice following a single head-only exposure to inhaled test materials using ASTM E981-84, standard test method for estimating sensory irritancy of airborne chemicals. Necropsy and histopathology data were evaluated due to the occurrence of unexpected pituitary lesions in sham control and exposure groups. Groups of four mice were restrained in body plethysmographs and exposed for 30 min to increasing dust concentrations of one of three test chemicals to assess the ability to cause sensory irritation. Sham control and test material-exposed mice were sacrificed after a single exposure and subjected to a complete necropsy and microscopic evaluation of the pituitary gland. Control mice remained in the animal room and were not restrained in the plethysmograph. Gross observation at necropsy showed pituitary lesions in one of seven unrestrained control mice (revised to zero of seven after microscopic examination). Seven of seven sham control mice had pituitary lesions, suggesting that the lesions were not related to test material exposure. Each test material-exposed group also had pituitary lesions with high incidence (52/60 for all groups combined), which was not exposure concentration-dependent. Microscopic evaluation of the pituitary glands revealed that darkening of the gland was due to hemorrhage and confirmed that the lesions developed with 100% incidence (19/19) in plethysmograph-housed animals. The rubber neck seal used to restrict animal movement in the plethysmograph appears to have caused an increase in pressure in the blood vessels in the pituitary gland; vessels then ruptured and hemorrhaged. This finding should not adversely affect sensory irritation responses evaluated with this method.


Subject(s)
Aerosols/toxicity , Irritants/toxicity , Pituitary Gland/drug effects , Pituitary Neoplasms/chemically induced , Animals , Hemorrhage , Male , Mice , Mice, Inbred Strains , Pituitary Gland/ultrastructure , Pituitary Neoplasms/pathology , Plethysmography , Toxicology/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...